Safety and Efficacy of Neoadjuvant Chemoimmunotherapy in Gastric Cancer Patients with a PD-L1 Positive Status: A Case Report.
Alexandra V AvgustinovichOlga V BakinaSergey G Afanas'evLiudmila V SpirinaAlexander M VolkovPublished in: Current issues in molecular biology (2023)
FLOT chemotherapy combined with immune checkpoint inhibitors showed high efficacy in gastric cancer patients with a positive PD-L1 status. Autophagy was involved in activating the tumor immunity. Further research is needed to clarify the mechanism of effective anticancer treatment.